Scilex Pharmaceuticals INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.9Mgeneral payments (2019-2025)
$4,892research payments (2019-2025)
19,247clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $560K
2020 $129K
2021 $329K
2022 $376K
2023 $509K
2024 $678K
2025 $318K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Physical Medicine & Rehabilitation $467K
Pain Medicine (Anesthesiology) $436K
Neurology (Psychiatry & Neurology) $248K
Family $229K
Family Medicine $159K
Interventional Pain Medicine $151K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Srinivas Nalamachu Overland Park, KS Physical Medicine & Rehabilitation $312,018.36
Scott Whitcup Los Angeles, CA Ophthalmology $118,625.42
Gerald Sacks Santa Monica, CA Pain Medicine (Anesthesiology) $101,696.14
Caitlin Innerfield Haddonfield, NJ Pain Medicine $85,428.98
Steven Cohen Chicago, IL Pain Medicine (Anesthesiology) $61,025.00
Zachary Mccormick Chicago, IL Physical Medicine & Rehabilitation $44,225.00
Charles Argoff Albany, NY Neurology (Psychiatry & Neurology) $41,416.83
Joseph Pergolizzi Naples, FL Pain Medicine (Anesthesiology) $41,072.45
Bill Mccarberg San Diego, CA Family Medicine $31,652.09
Michael Shapiro Carson City, NV $26,907.50

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.